查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2085521

馬用藥品和補充劑市場：2026-2032年全球市場預測（按產品類型、治療領域、給藥途徑、劑型、最終用戶和分銷管道分類）

Equine Pharmaceuticals & Supplements Market by Product Type, Therapeutic Category, Route Of Administration, Formulation, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，馬用藥品和補充劑市場將成長至 15.6 億美元，複合年成長率為 6.08%。

主要市場統計數據
基準年 2025 10.3億美元
預計年份：2026年 10.8億美元
預測年份 2032 15.6億美元
複合年成長率 (%) 6.08%

在人們對馬匹健康、運動表現、福利和合理用藥的期望不斷提高的推動下，馬匹藥品和營養補充劑市場正在不斷發展，涵蓋賽馬、運動馬、種馬、休閒馬和役用馬等各個領域。市場需求包括抗感染藥物、抗發炎藥物、驅蟲藥、疫苗、生殖藥物、皮膚科產品、消化系統支援產品、關節保健補充劑、電解質、鎮靜劑和營養型運動表現支援產品。

對製造商而言，成長最強勁的產品領域在於那些兼具臨床可靠性、標籤透明度、風險評估和易用性的產品。雖然獸醫建議在處方箋馬藥中仍然發揮核心作用，但膳食補充劑品牌之間的競爭主要體現在成分品質、偏好、第三方檢測以及符合動物健康法規和市場競爭規則的循證功效聲明上。

馬匹健康領域的變革性變化

馬匹醫療保健的格局正從被動治療轉向預防保健，馬主們開始及早投資於疫苗接種、寄生蟲防治、運動支持、腸胃健康和營養補充。這項轉變的促進因素包括賽馬競技生涯的延長、伴侶馬匹飼養量的增加，以及人們對馬匹在專業和休閒環境中健康福祉的日益成長的期望。

人工智慧（AI）的累積影響

人工智慧 (AI) 正透過快速訊號檢測、預測性庫存規劃、配方篩檢和現場藥物安全監測，開始對馬用藥品和補充劑產生影響。利用人工智慧分析獸醫記錄、不利事件報告、實驗室結果和穿戴式裝置數據，可以識別新出現的安全趨勢，並支援更快速的產品生命週期管理。

對關鍵區域的洞察

北美地區憑藉其完善的馬匹獸醫基礎設施、大量的運動和休閒馬匹以及在伴侶動物護理方面的高額支出，仍然是一個高價值地區。美國在品牌馬匹藥品、特殊營養補充劑和競技馬匹健康計劃方面尤其重要，而加拿大則受益於其組織完善的馬術比賽、繁殖活動和獸醫主導的醫療服務。

關鍵群體特定見解

在東協市場，隨著可支配收入的成長和人們對休閒馬術運動興趣的日益濃厚，馬術俱樂部、賽馬場和獸醫服務的重要性在各國不斷提升。海灣合作理事會（GCC）地區是馬匹營養補充劑、關節保健產品、電解質補充劑、腸胃保健產品和恢復保健產品的巨大市場潛力所在，因為高價值的阿拉伯馬和耐力賽在炎熱氣候下需要嚴格的健康管理。

主要國家的概況

在美國，賽馬、運動馬匹、馬匹繁殖和休閒馬匹護理的需求是主要促進因素，獸醫對處方藥和可靠營養補充劑的採納起著重要作用。在加拿大、墨西哥和巴西，賽馬、牧場、牛仔競技、運動馬匹和役用馬匹的健康照護支撐著市場需求，為寄生蟲控制、抗發炎療法、疫苗接種、電解質補充和肌肉骨骼營養補充劑等領域帶來了商機。英國、德國、法國、義大利和西班牙仍然是重要的歐洲市場，這要歸功於馬術運動、繁殖計劃、賽馬傳統和成熟的獸醫服務。同時，在俄羅斯，市場需求受到區域可及性、監管複雜性和分銷限制的影響。

為行業領導者提供的實用建議

產業領導者應優先考慮提升獸醫信譽，投資於對照試驗、透明揭露成分資訊、穩定性測試、殘留風險評估和上市後安全監測。那些不誇大藥物樣效果、且能用事實佐證其宣傳的品牌，能夠與獸醫、馴馬師、馬主、育種者和監管機構建立更牢固的信任關係。

調查方法

本執行摘要基於對檢驗的公開資訊來源的系統性審查，包括獸醫法律規範、動物健康指南、馬術比賽用藥規定、牲畜和馬匹種群官方文件以及已發表的獸醫文獻。本分析著重於可觀察的需求促進因素和監管趨勢，而非未經證實的市場規模估計值。

結論

馬用藥品和營養補充品市場正朝著實證、以福利為中心、數位化支持的照護模式轉變。預防醫學、精準營養、合理使用抗菌藥物以及符合競爭法規的性能支持，正在影響產品開發和品牌定位。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：馬用藥品和補充品市場：依產品類型分類

  • 製藥
  • 補充

第8章：馬用藥品和補充品市場：依治療類別分類

  • 麻醉劑
  • 抗感染藥物
    • Aminoglycosides抗生素
    • 大環內酯類抗生素
    • 青黴素類抗生素
    • 磺胺類藥物藥物
    • 四環黴素抗生素
  • 抗發炎藥
    • 皮質類固醇
    • NSAIDs
  • 心血管藥物
  • 胃腸道藥物
  • 荷爾蒙製劑
  • 神經系統藥物
  • 疫苗

第9章：馬用藥品和補充品市場：依給藥途徑分類

  • 注射藥物
    • 肌肉內部
    • 靜脈
    • 皮下
  • 口服
    • 粉末
    • 糖漿
    • 藥片
  • 外用

第10章：馬用藥品和補充品市場：按劑型分類

  • 奶油
  • 乳液
  • 凝膠
  • 粉末
  • 解決方案
  • 藥片

第11章：馬用藥品和補充品市場：按最終用戶分類

  • 馬匹養殖場
  • 研究機構與相關人員
  • 獸醫診所和上門服務
  • 動物醫院

第12章：馬用藥品和補充劑市場：按分銷管道分類

  • 網路藥房
  • 零售藥房
  • 獸醫醫院和診所
  • 獸藥

第13章：馬用藥品和補充品市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：馬用藥品和補充品市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：馬用藥品和補充品市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Aurora Pharmaceutical, Inc.
  • Biogenesis Bago
  • Biovac Ltd.
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Chanelle Pharma
  • China Animal Husbandary
  • Dechra Pharmaceuticals PLC
  • ECO-Animal Health Ltd.
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intas Animal Health
  • Laboratorio Drag Pharma Chile Invetec SA
  • Merck Animal Health
  • Neogen Corporation
  • Norbrook Laboratories Limited
  • Phibro Animal Health
  • Teknofarma Srl
  • Vetoquinol Group
  • Vetpharma Animal Health SL by Insud Pharma SLU
  • Virbac SA
  • Zendal group
  • Zoetis Inc.
Product Code: MRR-4348D129FACA

The Equine Pharmaceuticals & Supplements Market is projected to grow by USD 1.56 billion at a CAGR of 6.08% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.03 billion
Estimated Year [2026] USD 1.08 billion
Forecast Year [2032] USD 1.56 billion
CAGR (%) 6.08%

The equine pharmaceuticals and supplements market is being reshaped by rising expectations for horse health, athletic performance, welfare, and compliant medication use across racing, sport, breeding, leisure, and working-horse populations. Demand spans anti-infectives, anti-inflammatory drugs, parasiticides, vaccines, reproductive therapies, dermatology products, digestive support, joint health supplements, electrolytes, calming formulations, and nutrition-based performance support.

For manufacturers, growth momentum is strongest where products combine clinical credibility, label transparency, residue-risk awareness, and convenient administration. Veterinarian recommendation remains central for prescription equine medicine, while supplement brands compete on ingredient quality, palatability, third-party testing, and evidence-based claims that align with animal health regulations and competition rules.

Transformative Shifts in the Equine Health Landscape

The landscape is shifting from reactive treatment toward preventive equine healthcare, with owners investing earlier in vaccination, parasite control, mobility support, gastric health, and nutritional supplementation. This shift is supported by longer athletic careers for performance horses, rising companion-horse ownership, and stronger welfare expectations across professional and recreational segments.

Regulatory scrutiny is also transforming product strategy. Authorities such as the FDA Center for Veterinary Medicine, the European Medicines Agency, and national veterinary regulators continue to emphasize drug safety, antimicrobial stewardship, pharmacovigilance, and truthful labeling. For supplement manufacturers, this increases the value of documented sourcing, validated quality systems, and claims that avoid crossing into unapproved drug territory.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence equine pharmaceuticals and supplements through faster signal detection, predictive inventory planning, formulation screening, and field-level pharmacovigilance. AI-enabled analysis of veterinary records, adverse event reports, lab results, and wearable data can help identify emerging safety patterns and support more responsive product lifecycle management.

The cumulative impact is especially relevant in precision nutrition and performance management. Algorithms can combine body condition, workload, age, breed, diet, climate, and recovery data to guide supplement recommendations, while computer vision and imaging analytics can support lameness assessment. The strongest commercial value will come from AI systems that remain transparent, veterinarian-supervised, and compliant with data privacy, animal welfare, and medical device expectations.

Key Regional Insights

North America remains a high-value region due to established equine veterinary infrastructure, large sport and leisure horse populations, and strong spending on companion-animal style care. The United States is particularly important for branded equine pharmaceuticals, specialty supplements, and performance-horse health programs, while Canada benefits from organized equestrian sport, breeding activity, and veterinary-led care.

Europe is shaped by strict veterinary medicine regulation, competition medication rules, and welfare-driven purchasing across racing, sport, and leisure segments. The European Medicines Agency framework and national authorities reinforce pharmacovigilance, responsible antimicrobial use, and compliant claims, making quality documentation critical for suppliers. Asia-Pacific is expanding as China, India, Japan, Australia, and South Korea invest in racing, breeding, leisure riding, and premium animal health services. Latin America, led by Brazil and Mexico, shows demand in racing, polo, rodeo, ranching, and working-horse health. The Middle East is influenced by endurance racing, Arabian horse breeding, and elite equine facilities, while Africa combines premium sport-horse demand with essential access needs for working equids supported by welfare and veterinary outreach programs.

Key Group Insights

ASEAN markets are gaining relevance as equestrian clubs, racing venues, and veterinary services expand in countries with rising disposable income and growing interest in leisure riding. The GCC is a premium opportunity for equine supplements, joint support, electrolytes, gastric support, and recovery products because high-value Arabian horses and endurance disciplines require disciplined health management in hot climates.

The European Union is a benchmark for regulatory compliance under modern veterinary medicinal product rules, including tighter controls on antimicrobial use and clearer expectations for pharmacovigilance. BRICS countries combine large animal populations with uneven but improving access to equine healthcare, creating demand for both essential medicines and premium performance products. G7 markets are mature, brand-sensitive, and evidence-driven, with high expectations for validated quality, traceability, and veterinarian endorsement. NATO-aligned markets generally show strong biosecurity awareness, structured veterinary services, and demand for reliable supply chains that can support consistent access to equine pharmaceuticals and supplements.

Key Country Insights

The United States leads demand through racing, sport horse, breeding, and recreational ownership, with veterinarians influencing prescription therapies and high-trust supplement adoption. Canada, Mexico, and Brazil support demand through racing, ranching, rodeo, sport, and working-horse health, with opportunities for parasite control, anti-inflammatory therapy, vaccination, electrolyte support, and musculoskeletal supplements. The United Kingdom, Germany, France, Italy, and Spain remain important European markets due to equestrian sport, breeding programs, racing traditions, and mature veterinary services, while Russia presents demand shaped by regional access, regulatory complexity, and distribution constraints.

China and India offer long-term potential as equine sport, leisure riding, and organized veterinary care develop alongside traditional working-horse use and breeding activities. Japan, Australia, and South Korea are advanced Asia-Pacific markets with strong racing ecosystems, high welfare expectations, structured veterinary oversight, and premium product adoption. Across these countries, success depends on local regulatory classification, veterinarian engagement, channel reliability, competition-rule awareness, residue-risk management, and documented product quality.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize veterinary credibility by investing in controlled studies, transparent ingredient documentation, stability testing, residue-risk assessment, and post-market safety monitoring. Brands that substantiate claims without overstating drug-like effects can build stronger trust with veterinarians, trainers, owners, breeders, and regulators.

Manufacturers should also diversify supply chains for active pharmaceutical ingredients, botanicals, minerals, and specialty nutrients while maintaining audit-ready quality systems. Digital education, competition-compliant labeling, palatable formats, and climate-appropriate products such as electrolytes, hydration support, and recovery formulations can improve adoption in both mature and emerging equine markets.

Research Methodology

This executive summary is based on a structured review of verified public sources, including veterinary regulatory frameworks, animal health guidance, equestrian sport medication rules, official livestock and horse population references, and published veterinary literature. The analysis emphasizes observable demand drivers and regulatory developments rather than unsupported market-size estimates.

The methodology integrates product-category mapping, regional adoption patterns, regulatory review, and stakeholder assessment across veterinarians, manufacturers, distributors, trainers, breeders, and horse owners. Insights were validated through triangulation of regulatory direction, equine healthcare practices, competition requirements, welfare standards, and documented trends in preventive animal health, precision nutrition, and performance management.

Conclusion

The equine pharmaceuticals and supplements market is moving toward evidence-led, welfare-centered, and digitally supported care. Preventive medicine, precision nutrition, antimicrobial stewardship, and competition-compliant performance support are defining product development and brand positioning.

Manufacturers that combine scientific validation, transparent labeling, reliable supply, and veterinarian engagement will be best positioned to strengthen trust and expand adoption. As AI, wearable monitoring, and data-driven nutrition become more practical, the market will reward companies that improve equine health outcomes while maintaining regulatory discipline, medication compliance, and owner confidence.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Equine Pharmaceuticals & Supplements Market, by Product Type

  • 7.1. Pharmaceuticals
  • 7.2. Supplements

8. Equine Pharmaceuticals & Supplements Market, by Therapeutic Category

  • 8.1. Anesthetic Agents
  • 8.2. Anti-Infectives
    • 8.2.1. Aminoglycosides
    • 8.2.2. Macrolides
    • 8.2.3. Penicillins
    • 8.2.4. Sulfonamides
    • 8.2.5. Tetracyclines
  • 8.3. Anti-Inflammatories
    • 8.3.1. Corticosteroids
    • 8.3.2. NSAIDs
  • 8.4. Cardiovascular Agents
  • 8.5. Gastrointestinal Agents
  • 8.6. Hormonal Preparations
  • 8.7. Nervous System Agents
  • 8.8. Vaccines

9. Equine Pharmaceuticals & Supplements Market, by Route Of Administration

  • 9.1. Injectable
    • 9.1.1. Intramuscular
    • 9.1.2. Intravenous
    • 9.1.3. Subcutaneous
  • 9.2. Oral
    • 9.2.1. Powders
    • 9.2.2. Syrups
    • 9.2.3. Tablets
  • 9.3. Topical

10. Equine Pharmaceuticals & Supplements Market, by Formulation

  • 10.1. Creams
  • 10.2. Emulsions
  • 10.3. Gels
  • 10.4. Powders
  • 10.5. Solutions
  • 10.6. Tablets

11. Equine Pharmaceuticals & Supplements Market, by End User

  • 11.1. Equine Farms
  • 11.2. Research Institutions & Academics
  • 11.3. Veterinary Clinics & Ambulatory Services
  • 11.4. Veterinary Hospitals

12. Equine Pharmaceuticals & Supplements Market, by Distribution Channel

  • 12.1. Online Pharmacies
  • 12.2. Retail Pharmacies
  • 12.3. Veterinary Hospitals & Clinics
  • 12.4. Veterinary Pharmacies

13. Equine Pharmaceuticals & Supplements Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Equine Pharmaceuticals & Supplements Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Equine Pharmaceuticals & Supplements Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Aurora Pharmaceutical, Inc.
  • 17.2. Biogenesis Bago
  • 17.3. Biovac Ltd.
  • 17.4. Boehringer Ingelheim GmbH
  • 17.5. Ceva Sante Animale
  • 17.6. Chanelle Pharma
  • 17.7. China Animal Husbandary
  • 17.8. Dechra Pharmaceuticals PLC
  • 17.9. ECO - Animal Health Ltd.
  • 17.10. Elanco Animal Health Incorporated
  • 17.11. Heska Corporation
  • 17.12. Hester Biosciences Limited
  • 17.13. Indian Immunologicals Ltd.
  • 17.14. Intas Animal Health
  • 17.15. Laboratorio Drag Pharma Chile Invetec S.A.
  • 17.16. Merck Animal Health
  • 17.17. Neogen Corporation
  • 17.18. Norbrook Laboratories Limited
  • 17.19. Phibro Animal Health
  • 17.20. Teknofarma S.r.l.
  • 17.21. Vetoquinol Group
  • 17.22. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
  • 17.23. Virbac S.A.
  • 17.24. Zendal group
  • 17.25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SUPPLEMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANESTHETIC AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANESTHETIC AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANESTHETIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MACROLIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MACROLIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MACROLIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PENICILLINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PENICILLINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PENICILLINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SULFONAMIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SULFONAMIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SULFONAMIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TETRACYCLINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TETRACYCLINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TETRACYCLINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NSAIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NSAIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NSAIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARDIOVASCULAR AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIOVASCULAR AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIOVASCULAR AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HORMONAL PREPARATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HORMONAL PREPARATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HORMONAL PREPARATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NERVOUS SYSTEM AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NERVOUS SYSTEM AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NERVOUS SYSTEM AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL POWDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SYRUPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SYRUPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SYRUPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CREAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CREAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CREAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL EMULSIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL EMULSIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL EMULSIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL POWDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL EQUINE FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL EQUINE FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL EQUINE FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL RESEARCH INSTITUTIONS & ACADEMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL RESEARCH INSTITUTIONS & ACADEMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL RESEARCH INSTITUTIONS & ACADEMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY CLINICS & AMBULATORY SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY CLINICS & AMBULATORY SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY CLINICS & AMBULATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. GCC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. GCC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 211. GCC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 212. GCC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 213. GCC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 215. GCC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 216. GCC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. GCC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. G7 EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 244. G7 EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 245. G7 EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 246. G7 EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 248. G7 EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 249. G7 EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. G7 EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. NATO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. NATO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 255. NATO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 256. NATO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 257. NATO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 259. NATO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 260. NATO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. NATO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 277. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 278. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 281. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 282. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 291. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 293. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 294. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 296. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 299. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 300. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 302. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 303. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 304. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 305. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 318. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 321. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 322. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 323. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 324. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 325. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 326. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 327. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018